Clinical and technical outcomes of Endovascular Aortic Repair (EVAR) in abdominal infrarenal Penetrating Aortic Ulcers (PAU)
Recruiting
- Conditions
- I71.9Aortic aneurysm of unspecified site, without mention of rupture
- Registration Number
- DRKS00028794
- Lead Sponsor
- niversitätsklinikum Heidelberg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patients who underwent endovascular treatment for an infrarenal penetrating aortic ulcer at the Department of Vascular Surgery and Endovascular Surgery at Heidelberg University Hospital between 1/1/2010 and 1/6/2022.
Exclusion Criteria
infectious PAU, age <18
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Technical success, mortality, re-interventions, endoleaks
- Secondary Outcome Measures
Name Time Method follow-up examinations, CT screening
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie aortic wall degeneration in abdominal infrarenal penetrating aortic ulcers (PAUs)?
How does endovascular aortic repair (EVAR) compare to open surgical repair for abdominal infrarenal PAUs in terms of long-term survival and complication rates?
Which biomarkers predict successful aneurysm exclusion and reduced risk of endoleaks after EVAR in patients with I71.9 abdominal infrarenal PAUs?
What are the incidence and management strategies for type I endoleaks following EVAR in abdominal infrarenal penetrating aortic ulcers (PAUs)?
What alternative endovascular techniques or devices are being evaluated for abdominal infrarenal PAUs compared to traditional EVAR methods?